Antiplatelet and anticoagulant use after myocardial infarction
- 1 May 1996
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 19 (5) , 357-365
- https://doi.org/10.1002/clc.4960190506
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Aspirin, platelets, and thrombosis: theory and practiceBlood, 1994
- Conjunctive antithrombotic therapy for thrombolysis in myocardial infarctionThe American Journal of Cardiology, 1993
- Prostanoid biosynthesis and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 1992
- A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic StrokeNew England Journal of Medicine, 1991
- Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.Proceedings of the National Academy of Sciences, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Collagenous proteins of blood vessels.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- XXXII. An account of the success of the bark of the willow in the cure of agues. In a letter to the Right Honourable George Earl of Macclesfield, President of R. S. from the Rev. Mr. Edward Stone, of Chipping-Norton in OxfordshirePhilosophical Transactions of the Royal Society of London, 1763